Different weight loss medications demonstrate varying gastrointestinal side effect profiles, which can inform treatment selection for patients particularly concerned about diarrhea
As prices drop, our commitment to safety remains consistent
doi: 10.1038/nm.3761 79 CoskunTUrvaSRoellWCQuHLoghinCMoyersJSet al
Drug selection Return the FDA-label schedule with dose labels and timing per step
depression, addictive disorders, eating disorders) weight regain or excessive weight loss gastrointestinal side effects or complications, including gall stones medication side effects due to altered pharmacokinetics bone health
In all GLP-1 RAs, liraglutide (23.31%, 657 severe outcomes out of 2,819 cases) had the highest severe proportion of GLP-1 RA-associated gastrointestinal AEs, and the lowest for dulaglutide (12.29%, 1,322 severe outcomes out of 9,435 cases)